Business
Prospects seem rosier for Senate passage of cannabis banking reform – but no guarantee
The push to pass major federal cannabis banking reform resumes in earnest Thursday during a Democratic-controlled U.S. Senate Banking Committee hearing about the challenges that a largely cash-based industry poses to small businesses and employees.
Guaranteed to enter the conversation is the much-anticipated Secure and Fair Enforcement (SAFE) Banking Act, which a bipartisan group of lawmakers in both chambers of Congress reintroduced in late April.
As observers note, the House of Representatives has passed SAFE Banking in some form seven times under Democratic leadership.
Prospects in Republican House Speaker Kevin McCarthy’s chamber are less certain, but the Senate is understood to be the main obstacle.
The Senate has never voted on the proposal, either on the floor or in committee, despite vocal support from Majority Leader Chuck Schumer, who on Saturday repeated an earlier (and unfulfilled) promise to get banking reform done.
It’s believed President Joe Biden would sign the bill into law if it were to reach his desk.
If he did so, federal banking regulators would be prohibited from punishing financial institutions that offer basic banking services to marijuana businesses following state law.
‘Step forward’
The fact that senators are formally entertaining the topic on Capitol Hill is by itself reason for enthusiasm among marijuana industry executives and representatives.
The bill’s introduction boosted shares in publicly traded multistate operators two weeks ago, which observers note is a sign of how little progress Congress has made on marijuana reform since the arrival of the multibillion-dollar U.S. cannabis industry.
Thursday’s hearing is best understood as “a meaningful step forward,” said Reggie Babin, a former chief counsel to Schumer who is now senior counsel at Akin Gump, an influential Washington DC law and lobbying firm.
“This appears to be setting up SAFE Banking for a thorough consideration in the Senate, which suggests we are moving past where we were,” Babin told MJBizDaily.
“This is a perquisite for a committee vote, which is a perquisite to floor consideration.”
But advancement to the floor of the full Senate for an up-or-down vote isn’t expected to happen this week.
The bill itself is not currently scheduled to receive full scrutiny and possible amendments in what’s called the “markup process,” generally considered a perquisite for full Senate consideration.
The timeline on that is ambiguous.
Another committee hearing with a markup will follow “soon,” staffers for Ohio Democratic Sen. Sherrod Brown, the committee chair, vowed to MJBizDaily via email.
There is bipartisan agreement on at least that much, as Ryann DuRant, a spokesperson for Republican Sen. Tim Scott, the ranking Republican member on the committee, told MJBizDaily.
“Ranking Member Scott has called for SAFE Banking to go through regular order so members of the Senate Committee on Banking, Housing, and Urban Affairs have the opportunity to debate and contribute to the bill,” she wrote in an email.
“The Ranking Member looks forward to a robust discussion on the topic in this week’s hearing.”
Observers say the list of witnesses that have been called to appear before the committee on Thursday might indicate the tenor of the conversation.
As of Monday, the only witnesses were Sens. Jeff Merkley, Democrat of Oregon, and Steve Daines, Republican of Montana, the current Senate sponsors who have sponsored the bill previously.
“Daines has always called for the bill to go through regular order and is glad that Senator Brown finally scheduled a hearing for the SAFE Banking Act,” Rachel Dumke, a Daines spokesperson, told MJBizDaily in an email.
“SAFE Banking has passed the House seven times with broad bipartisan support and the Senator believes there is the strong bipartisan support in the Senate and he will be working to build a consensus here to get the bill passed.”
The process
Experts in Senate procedure note that SAFE Banking does not need a markup or a committee vote to become law.
They also note that efforts to attach SAFE Banking to must-pass legislation such as the annual defense spending bill failed in the previous Congress, when the Senate ran out of time to consider SAFE Banking via “regular” order.
And cannabis advocates will recall the Senate held a hearing in 2019 that’s very similar to what’s scheduled for Thursday.
But enough has changed in the ensuing four years for industry advocates to be bullish, said Aaron Smith, executive director of the DC-based National Cannabis Industry Association, which lobbies for small and medium-sized marijuana businesses on Capitol Hill.
The number of states that have legalized adult-use marijuana has more than doubled, from 11 states to 22, with Maryland the next state scheduled to roll out recreational sales, on July 1.
Also, conservative strongholds such as Kentucky, the home state of Senate Minority Leader Mitch McConnell, have passed laws allowing medical marijuana.
Forty states have authorized full-fledged MMJ markets.
“This translates into significantly more representation of states with some kind of cannabis industry in the Senate, including on the Republican side of the aisle,” Smith wrote in an email.
“This coupled with the fact that the House has passed SAFE with uncommonly bipartisan majorities seven times and unprecedented institutional support for reform, gives us hope that the Senate will finally approve the legislation this year,” he added.
Ed Conklin, executive director of the U.S. Cannabis Council, also is encouraged, saying in an email that the hearing represents “a crucial step on the way to passing the SAFE Banking Act.”
In addition to blanket opposition to hitching SAFE to larger legislation, past Republican opposition to the bill, spelled out in a U.S. Department of Justice memo made public in early December, hinged on some ambiguities that the DOJ feared could complicate investigations of money laundering.
Current bill language reflects those concerns.
And it’s understood that progressive Democrats will not repeat earlier demands for SAFE to be packaged with social justice initiatives such as equity programs, but rather, the measure will be considered along with expungements for federal marijuana crimes as well as clarified permissions for cannabis users to legally own firearms.
Long odds, bad vote
The odds of SAFE passing, however, remain long.
Skeptics point out that the Senate has already considered a cannabis question this year and rejected it.
Under the Senate’s cloture rule, 60 votes are needed to end debate on a bill and bring it to an up-or-down vote.
On April 26, a motion to end debate and hold an up-or-down vote on a bill that would have allowed the Veterans Administration to run a clinical study on cannabis’ efficacy with chronic pain and PTSD in military veterans was rejected 57-42, with one abstention.
“I don’t think the hearing this week is going to suddenly usher SAFE Banking through the Senate,” said John Hudak, the director of Maine’s Office of Cannabis Policy and a former Brookings Institute fellow.
“But I think it starts the process of changing hearts and minds, which I think is very important.”
To get to 60 votes, he said, “you’ve got to pick off some people who are cannabis skeptics, and SAFE Banking is a nice comfortable place for some members to dip their toes into cannabis.”
However, “I am deeply skeptical the 118th Congress is going to be the one to push SAFE Banking through,” Hudak added.
Source: https://mjbizdaily.com/what-are-prospects-for-senate-passage-of-cannabis-banking-reform/
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy